Procedural characteristics
| Characteristic | Intervention (n=150) | Control (n=150) | p Value |
|---|---|---|---|
| Extent of CAD | |||
| Three-vessel or LM disease | 45 (30) | 49 (33) | 0.59 |
| SVG disease | 12 (8) | 23 (15) | 0.048 |
| PCI lesions | |||
| Left main | 10 (7) | 11 (7) | 0.81 |
| LAD or diagonal | 76 (51) | 72 (48) | 0.64 |
| SVG | 11 (7) | 17 (11) | 0.23 |
| CTO | 6 (4) | 6 (4) | 0.99 |
| Bifurcation (s) | 78 (52) | 63 (42) | 0.09 |
| Ostial lesion (s) | 53 (35) | 48 (32) | 0.57 |
| Calcified lesion (s) | 68 (45) | 71 (48) | 0.69 |
| In-stent restenosis | 15 (10) | 14 (9) | 0.86 |
| Thrombus | 10 (7) | 5 (3) | 0.19 |
| ACC/AHA type C | 89 (59) | 92 (62) | 0.67 |
| DES implanted | 0.52 | ||
| Sirolimus-eluting stent | 91 (61) | 101 (67) | |
| Paclitaxel-eluting stent | 16 (11) | 10 (6.7) | |
| Everolimus-eluting stent | 18 (12) | 17 (11) | |
| Zotarolimus-eluting stent | 8 (5.3) | 4 (2.7) | |
| Combined types | 17 (11) | 18 (12) | |
| Other characteristics | |||
| Total stent length (mm) | 33 (18–54) | 36 (23–59) | 0.26 |
| Smallest stent diameter (mm) | 2.5 (2.5–3.0) | 2.5 (2.5–3.0) | 0.67 |
| Highest in-stent pressure of largest balloon applied (atm) | 20 (18–22) | 20 (18–22) | 0.29 |
| Number of vessels treated | 1 (1–1) | 1 (1–2) | 0.04 |
| Number of stents implanted | 1 (1–2) | 2 (1–3) | 0.08 |
Values are n (%) or median (25th–75th centile).
ACC/AHA, American College of Cardiology/American Heart Association; CAD, coronary artery disease; CTO, chronic total occlusion; DES, drug-eluting stent; LAD, left anterior descending; LM, left main; PCI, percutaneous coronary intervention; SVG, saphenous vein graft.